Senior Product Manager at Unlearn AI

San Francisco, California, United States

Apply Now

$170,000 – $220,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Artificial Intelligence, SoftwareIndustries

Requirements

Candidates must have at least 5 years of experience as a product manager in a technology company, working on technology-powered products. A Bachelor's degree or equivalent practical experience with demonstrated knowledge of the clinical development space is required. The ideal candidate will have proven ability to ship high-impact products quickly, solve complex problems with many constraints, assess risks, and present data-informed narratives. They must also demonstrate the ability to learn and partner with engineering, design, finance, sales, and marketing teams, collaborate effectively in team environments, and act as a decisive decision-maker. A strong technical understanding from high-level abstractions to the fundamental details is necessary, along with the ability to independently gather and analyze data to create insightful stories. A passion for the company's mission and an owner's mindset are essential. Experience in the biopharma industry is a plus.

Responsibilities

The Senior Product Manager will be responsible for building a new, computationally-focused and AI approach to solving important problems in healthcare. This role requires a broad knowledge base to collaborate with technology, marketing, and business development teams, and to develop a deep understanding of customer and user problems in biopharma clinical trials. The product manager will lead product discovery and delivery efforts, ensuring the successful launch of high-impact products.

Skills

Product Management

Machine Learning

Generative AI

Clinical Trials

Forecasting

Software

Team Collaboration

Storytelling

Unlearn AI

Creates AI-driven digital twins for healthcare

About Unlearn AI

Unlearn.AI creates digital twins of patients using artificial intelligence, which are virtual replicas that simulate potential health outcomes. This technology allows healthcare providers to predict how a patient's health may change over time, leading to more informed treatment decisions. The primary clients include healthcare providers and pharmaceutical companies, who can use these digital twins in clinical trials to simulate control groups, potentially speeding up drug development and approval processes. Unlearn.AI differentiates itself by offering a unique simulation technology that reduces the need for actual human control groups, which can save time and resources. The company's goal is to enhance decision-making in patient care and drug development through precise health outcome predictions.

San Francisco, CaliforniaHeadquarters

2017Year Founded

$127.1MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Commuter Benefits

Paid Parental Leave

Company Equity

Risks

Over-reliance on AI data may lead to inaccuracies in trial outcomes.

Increased competition from companies like Consilx and Aicure could impact market share.

High clinical trial failure rates could affect perception of Unlearn AI's effectiveness.

Differentiation

Unlearn AI's TwinRCT uses digital twins to enhance clinical trial precision.

The company offers TrialPioneer, a free tool for innovative trial design exploration.

Unlearn AI's digital twin technology reduces the need for human control groups.

Upsides

AI in clinical trials market expected to reach $2.74 billion by 2030.

Partnership with ProJenX highlights AI's potential in specific therapeutic areas.

TwinRCT 3.0 enhances decision-making in Phase II trials for better outcomes.

Land your dream remote job 3x faster with AI

Try Jobo Free